Thymoquinone induces apoptosis in oral cancer cells through p38β inhibition

American Journal of Chinese Medicine

Volumn 41, Issue 3, 2013, Pages 683-696

  Abdelfadil, Ehab ^a,c   Cheng, Ya Hsin ^b   Bau, Da Tian ⁱ   Ting, Wei Jen ^a   Chen, Li Mien ^d,e   Hsu, Hsi Hsien ^f   Lin, Yueh Min ^g,h   Chen, Ray Jade ^j   Tsai, Fu Jenn ^a   Tsai, Chang Hai ^k   Huang, Chih Yang ^a,k  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c MANSOURA UNIVERSITY   (Egypt)

^d CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^e TAICHUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^f MACKAY MEMORIAL HOSPITAL   (Taiwan)

^g CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^h JEN TEH JUNIOR COLLEGE OF MEDICINE   (Taiwan)

ⁱ CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^j TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^k ASIA UNIVERSITY   (Taiwan)

more..

Author keywords

Oral Cancer; p38 MAPK; p38 MAPK; Thymoquinone

Indexed keywords

ANTINEOPLASTIC AGENT; MITOGEN ACTIVATED PROTEIN KINASE 11; MITOGEN ACTIVATED PROTEIN KINASE 14; THYMOQUINONE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME INHIBITION; MALIGNANT TRANSFORMATION; MOUSE; MOUTH CANCER; NONHUMAN;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BENZOQUINONES; CELL LINE; CELL LINE, TUMOR; DOWN-REGULATION; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 11; MITOGEN-ACTIVATED PROTEIN KINASE 14; MOUTH MUCOSA; MOUTH NEOPLASMS; NEOPLASMS, SQUAMOUS CELL; NIGELLA SATIVA; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 84878379041     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X1350047X     Document Type: Article

References (68)

1. Al-Ali, A., A.A. Alkhawajah, M.A. Randhawa, and N.A. Shaikh. Oral and intraperitoneal LD50 of thymoquinone, an active principle of Nigella sativa, in mice and rats. J. Ayub. Med. Coll. Abbottabad 20: 25-27, 2008.
2. Ali, B.H. and G. Blunden. Pharmacological and toxicological properties of Nigella sativa. Phytother. Res. 17: 299-305, 2003. (Pubitemid 36565330)
3. Banerjee, S., S. Padhye, A. Azmi, Z. Wang, P.A. Philip, O. Kucuk, F.H. Sarkar and R.M. Mohammad. Review on molecular and therapeutic potential of thymoquinone in cancer. Nutr. Cancer 62: 938-946, 2010.
4. Birbach, A., D. Eisenbarth, N. Kozakowski, E. Ladenhauf, M. Schmidt-Supprian and J.A. Schmid. Persistent inflammation leads to proliferative neoplasia and loss of smooth muscle cells in a prostate tumor model. Neoplasia 13: 692-703, 2011.
5. Brash, D.E. and J. Ponten. Skin precancer. Cancer Surv. 32: 69-113, 1998. (Pubitemid 28432245)
6. Brinkman, B.M. and D.T. Wong. Disease mechanism and biomarkers of oral squamous cell carcinoma. Curr. Opin. Oncol. 18: 228-233, 2006. (Pubitemid 43740416)
7. Cerezo-Guisado, M.I., R.P. del, G. Remy, Y. Kuma, J.S. Arthur, D. Gallego-Ortega and A. Cuenda. Evidence of p38gamma and p38delta involvement in cell transformation processes. Carcinogenesis 32: 1093-1099, 2011.
8. Chehl, N., G. Chipitsyna, Q. Gong, C.J. Yeo and H.A. Arafat. Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells. HPB (Oxford) 11: 373-381, 2009.
9. Chin, D., G.M. Boyle, S. Porceddu, D.R. Theile, P.G. Parsons and W.B. Coman. Head and neck cancer: past, present and future. Expert Rev. Anticancer Ther. 6: 1111-1118, 2006. (Pubitemid 44203388)
10. Comes, F., A. Matrone, P. Lastella, B. Nico, F.C. Susca, R. Bagnulo, G. Ingravallo, S. Modica, S.G. Lo and A. Moschetta. A novel cell type-specific role of p38alpha in the control of autophagy and cell death in colorectal cancer cells. Cell Death Differ. 14: 693-702, 2007. (Pubitemid 46444507)
11. Cuenda, A., J. Rouse, Y.N. Doza, R. Meier, P. Cohen, T.F. Gallagher, P.R. Young and J.C. Lee. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364: 229-233, 1995.
12. Cuenda, A. and S. Rousseau. p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim. Biophys. Acta 1773: 1358-1375, 2007. (Pubitemid 47125981)
13. Eckert, R.L., T. Efimova, S. Balasubramanian, J.F. Crish, F. Bone and S. Dashti. p38 Mitogenactivated protein kinases on the body surface-a function for p38 delta. J. Invest. Dermatol. 120: 823-828, 2003. (Pubitemid 36529085)
14. El-Mahdy, M.A., Q. Zhu, Q.E. Wang, G. Wani and A.A. Wani. Thymoquinone induces apoptosis through activation of caspase-8 and mitochondrial events in p53-null myeloblastic leukemia HL-60 cells. Int. J. Cancer 117: 409-417, 2005. (Pubitemid 41429564)
15. Evan, G and T. Littlewood. A matter of life and cell death. Science 281: 1317-1322, 1998. (Pubitemid 28406818)
16. Gadewal, N.S. and S.M. Zingde. Database and interaction network of genes involved in oral cancer: Version II. Bioinformation 6: 169-170, 2011.
17. Gauthier, M.L., C.R. Pickering, C.J. Miller, C.A. Fordyce, K.L. Chew, H.K. Berman and T.D. Tlsty. p38 regulates cyclooxygenase-2 in human mammary epithelial cells and is activated in premalignant tissue. Cancer Res. 65: 1792-1799, 2005. (Pubitemid 40478606)
18. Gonzalez-Garcia, R., L. Naval-Gias, L. Roman-Romero, J. Sastre-Perez and F.J. Rodriguez-Campo. Local recurrences and second primary tumors from squamous cell carcinoma of the oral cavity: a retrospective analytic study of 500 patients. Head Neck 31: 1168-1180, 2009.
19. Guan, Z., S.Y. Buckman, A.P. Pentland, D.J. Templeton and A.R. Morrison. Induction of cyclooxygenase-2 by the activated MEKK1 ! SEK1/MKK4 ! p38 mitogen-activated protein kinase pathway. J. Biol. Chem. 273: 12901-12908, 1998. (Pubitemid 28246849)
20. Hallahan, A.R., J.I. Pritchard, R.A. Chandraratna, R.G. Ellenbogen, J.R. Geyer, R.P. Overland, A.D. Strand, S.J. Tapscott and J.M. Olson. BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect. Nat. Med. 9: 1033-1038, 2003. (Pubitemid 37021783)
21. Han, J., J.D. Lee, P.S. Tobias and R.J. Ulevitch. Endotoxin induces rapid protein tyrosine phosphorylation in 70Z/3 cells expressing CD14. J. Biol. Chem. 268: 25009-25014, 1993. (Pubitemid 23335522)
22. Harris, C.C. p53 tumor suppressor gene: from the basic research laboratory to the clinic-an abridged historical perspective. Carcinogenesis 17: 1187-1198, 1996. (Pubitemid 26196329)
23. Hildesheim, J., D.V. Bulavin, M.R. Anver, W.G. Alvord, M.C. Hollander, L. Vardanian and A.J. Fornace, Jr. Gadd45a protects against UV irradiation-induced skin tumors, and promotes apoptosis and stress signaling via MAPK and p53. Cancer Res. 62: 7305-7315, 2002. (Pubitemid 36025254)
24. Holmes, W.F., D.R. Soprano and K.J. Soprano. Early events in the induction of apoptosis in ovarian carcinoma cells by CD437: activation of the p38 MAP kinase signal pathway. Oncogene 22: 6377-6386, 2003. (Pubitemid 37281686)
25. Hong, S.X., I.H. Cha, E.W. Lee and J. Kim. Mandibular invasion of lower gingival carcinoma in the molar region: its clinical implications on the surgical management. Int. J. Oral Maxillofac. Surg. 30: 130-138, 2001. (Pubitemid 33397576)
26. Hui, L., L. Bakiri., E. Stepniak and E.F. Wagner. p38alpha: a suppressor of cell proliferation and tumorigenesis. Cell Cycle 6: 2429-2433, 2007. (Pubitemid 350058657)
27. Hwang, J.M., W.J. Ting, H.C. Wu, Y.J. Chen, F.J. Tsai, P.Y. Chen, C.Y. Liu, L.C. Chou, S.C. Kuo and C.Y. Huang. KHC-4 anti-cancer effects on human PC3 prostate cancer cell line. Am. J. Chin. Med. 40: 1063-1071, 2012.
28. Iyoda, K., Y. Sasaki, M. Horimoto, T. Toyama, T. Yakushijin, M. Sakakibara, T. Takehara, J. Fujimoto. M. Hori and J.R. Wands. Involvement of the p38 mitogen-activated protein kinase cascade in hepatocellular carcinoma. Cancer 97: 3017-3026, 2003. (Pubitemid 36676256)
29. Jiang, Y., C. Chen, Z. Li, W. Guo, J.A. Gegner, S. Lin and J. Han. Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta). J. Biol. Chem. 271: 17920-17926, 1996. (Pubitemid 26250772)
30. Jiang, Y., H. Gram, M. Zhao, L. New, J. Gu, L. Feng, P.F. Di, R.J. Ulevitch and J. Han. Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38delta. J. Biol. Chem. 272: 30122-30128, 1997. (Pubitemid 27512210)
31. Johnson, G.L. and R. Lapadat. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911-1912, 2002. (Pubitemid 35425238)
32. Kanter, M., M. Akpolat and C. Aktas. Protective effects of the volatile oil of Nigella sativa seeds on beta-cell damage in streptozotocin-induced diabetic rats: a light and electron microscopic study. J. Mol. Histol. 40: 379-385, 2009.
33. Kim, A.L., J.M. Labasi, Y. Zhu, X. Tang, K. McClure, C.A. Gabel, M. Athar and D.R. Bickers. Role of p38 MAPK in UVB-induced inflammatory responses in the skin of SKH-1 hairless mice. J. Invest. Dermatol. 124: 1318-1325, 2005. (Pubitemid 40847422)
34. Kurosu, T, Y. Takahashi, T. Fukuda, T., Koyama. T. Miki and O. Miura. p38 MAP kinase plays a role in G2 checkpoint activation and inhibits apoptosis of human B cell lymphoma cells treated with etoposide. Apoptosis 10: 1111-1120, 2005. (Pubitemid 41285586)
35. Losa, J.H., C.C. Parada, J.G. Viniegra, V.J. Sanchez-Arevalo Lobo, S. Cajal and R. Sanchez-Prieto. Role of the p38 MAPK pathway in cisplatin-based therapy. Oncogene 22: 3998-4006, 2003. (Pubitemid 36819640)
36. Mackay, K. and D. Mochly-Rosen. An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia. J. Biol. Chem. 274: 6272-6279, 1999. (Pubitemid 29111038)
37. Matrone, A., V. Grossi, F. Chiacchiera, E. Fina, M. Cappellari, A.M. Caringella, N.E. Di, G. Loverro and C. Simone. p38alpha is required for ovarian cancer cell metabolism and survival. Int. J. Gynecol. Cancer 20: 203-211, 2010.
38. Mendoza, R.A., E.E. Moody, M.I. Enriquez, S.M. Mejia and G. Thordarson. Tumorigenicity of MCF-7 human breast cancer cells lacking the p38alpha mitogen-activated protein kinase. J. Endocrinol. 208: 11-19, 2011.
39. Mertens, S., M. Craxton and M. Goedert. SAP kinase-3, a new member of the family of mammalian stress-activated protein kinases. FEBS. Lett. 383: 273-276. 1996. (Pubitemid 26104075)
40. McCormick, D.L., J.M. Phillips, T.L. Horn, W.D. Johnson, V.E. Steele and R.A. Lubet. Overexpression of cyclooxygenase-2 in rat oral cancers and prevention of oral carcinogenesis in rats by selective and nonselective COX inhibitors. Cancer Prev. Res. 3: 73-81, 2010.
41. McDowell, J.D. An overview of epidemiology and common risk factors for oral squamous cell carcinoma. Otolaryngol. Clin. North Am. 39: 277-294, 2006.
42. Mendoza, R.A., E.E. Moody, M.I. Enriquez, S.M. Mejia and G. Thordarson. Tumorigenicity of MCF-7 human breast cancer cells lacking the p38alpha mitogen-activated protein kinase. J. Endocrinol. 208: 11-19, 2011.
43. Mertens, S., M. Craxton and M. Goedert. SAP kinase-3, a new member of the family of mammalian stress-activated protein kinases. FEBS. Lett. 383: 273-276, 1996. (Pubitemid 26104075)
44. Morger, R., C.A. Ramseier, T.D. Rees, W.B. Burgin and M.M. Bornstein. Oral mucosal findings related to tobacco use and alcohol consumption: a study on Swiss army recruits involving selfreported and clinical data. Oral Health Prev. Dent. 8: 143-151, 2010.
45. Nagi, M.N. and M.A. Mansour. Protective effect of thymoquinone against doxorubicin-induced cardiotoxicity in rats: a possible mechanism of protection. Pharmacol. Res. 41: 283-289, 2000. (Pubitemid 30663132)
46. Nebreda, A.R. and A. Porras. p38 MAP kinases: beyond the stress response. Trends. Biochem. Sci. 25: 257-260, 2000. (Pubitemid 30333380)
47. Nemoto, S., J. Xiang, S. Huang and A. Lin. Induction of apoptosis by SB202190 through inhibition of p38beta mitogen-activated protein kinase. J. Biol. Chem. 273: 16415-16420, 1998. (Pubitemid 28311422)
48. Nomura, T., T. Shibahara, N.H. Cui and H. Noma. Patterns of mandibular invasion by gingival squamous cell carcinoma. J. Oral Maxillofac. Surg. 63: 1489-1493, 2005. (Pubitemid 41355012)
49. Olson, J.M. and A.R. Hallahan. p38 MAP kinase: a convergence point in cancer therapy. Trends Mol. Med. 10: 125-129, 2004. (Pubitemid 38293348)
50. Ow, T.J. and J.N. Myers. Current management of advanced resectable oral cavity squamous cell carcinoma. Clin. Exp. Otorhinolaryngol. 4: 1-10, 2011.
51. Paillas, S., F. Boissiere, F. Bibeau, A. Denouel, C. Mollevi, A. Causse, V. Denis, N. Vezzio-Vie, L. Marzi and C. Cortijo. Targeting the p38 MAPK pathway inhibits irinotecan resistance in colon adenocarcinoma. Cancer Res. 71: 1041-1049, 2011.
52. Panchal, R.G. Novel therapeutic strategies to selectively kill cancer cells. Biochem. Pharmacol. 55: 247-252, 1998. (Pubitemid 28021735)
53. Piemonte, E.D., Lazos, J.P. and M. Brunotto. Relationship between chronic trauma of the oral mucosa, oral potentially malignant disorders and oral cancer. J. Oral Pathol. Med. 39: 513-517, 2010.
54. Porras, A., S. Zuluaga, E. Black, A. Valladares, A.M. Alvarez, C. Ambrosino, M. Benito and A.R. Nebreda. P38 alpha mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli. Mol. Biol. Cell 15: 922-933, 2004. (Pubitemid 38146504)
55. Rennemo, E., U. Zatterstrom and M. Boysen. Outcome of local failures after oral cancer-recurrence vs. second primary. J. Oral Pathol. Med. 39: 657-661, 2010.
56. Rhodus, N.L., B. Cheng, S. Myers, L. Miller, V. Ho and F. Ondrey. The feasibility of monitoring NF-kappaB associated cytokines: TNF-alpha, IL-1alpha, IL-6, and IL-8 in whole saliva for the malignant transformation of oral lichen planus. Mol. Carcinog. 44: 77-82, 2005. (Pubitemid 41397172)
57. Rose, B.S., J.H. Jeong, S.K. Nath, S.M. Lu and L.K. Mell. Population-based study of competing mortality in head and neck cancer. J. Clin. Oncol. 29: 3503-3509. 2011.
58. Schindler, J.F, J.B. Monahan and W.G. Smith. p38 pathway kinases as anti-inflammatory drug targets. J. Dent. Res. 86: 800-881, 2007.
59. Scott, S.E., E.A. Grunfeld, J. Main and M. McGurk. Patient delay in oral cancer: a qualitative study of patients' experiences. Psychooncology 15: 474-485, 2006. (Pubitemid 44018683)
60. Shafi, G., A. Munshi, T.N. Hasan, A.A. Alshatwi, A, Jyothy and D.K. Lei. Induction of apoptosis in HeLa cells by chloroform fraction of seed extracts of Nigella sativa. Cancer Cell Int. 9: 29, 2009.
61. Shah, J.P. Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract. Am. J. Surg. 160: 405-409, 1990. (Pubitemid 20346332)
62. Slaughter, D.P., H.W Southwick and W. Smejkal. Field Cancerization in Oral Stratified Squamous Epithelium; Clinical Implications of Multicentric Origin. Cancer 6: 963-968, 1953.
63. Spencer, K.R., J.W. Ferguson and D. Wiesenfeld. Current concepts in the management of oral squamous cell carcinoma. Aust. Dent. J. 47: 284-289, 2002.
64. Takekawa, M., M. Adachi, A. Nakahata, I. Nakayama, F. Itoh, H. Tsukuda, Y. Taya and K. Imai. p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation. EMBO J. 19: 6517-6526, 2000.
65. Vaillancourt, F., P. Silva, Q. Shi, H. Fahmi, J.C. Fernandes and M. Benderdour. Elucidation of molecular mechanisms underlying the protective effects of thymoquinone against rheumatoid arthritis. J. Cell. Biochem. 112: 107-117, 2011.
66. Wang, Y., S. Huang, V.P. Sah, J. Ross, J.H. Brown, J. Han and K.R. Chien. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J. Biol. Chem. 273: 2161-2168, 1998. (Pubitemid 28069266)
67. Won, J.H. Cyclooxygenase-2: a potential target in human cancer. Cancer Res. Treat. 36: 161-162, 2004.
68. Worthen, D.R., O.A. Ghosheh and P.A. Crooks. The in vitro anti-tumor activity of some crude and purified components of blackseed, Nigella sativa L. Anticancer. Res. 18: 1527-1532, 1998. (Pubitemid 28342555)